Am J Psychiatry. 1990 Aug;147(8):1018-20.

Bupropion treatment of attention-deficit hyperactivity disorder in adults.

Source

Department of Psychiatry, University of Utah School of Medicine, Salt Lake City 84182.

Abstract

The authors treated 19 adults with attention-deficit hyperactivity disorder with an open trial of bupropion. These patients had received maintenance stimulant medication or monoamine oxidase inhibitors for an average of 3.7 years. Fourteen of the patients experienced moderate to marked benefit from bupropion; ten of these patients chose to continue bupropion rather than their former medication. These results suggest that bupropion may be an alternative to stimulants in treating some adults with attention-deficit hyperactivity disorder.

PMID:: 2115746; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

Review Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. [Adv Ther. 2009]
Review Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
Verbeeck W, Tuinier S, Bekkering GE. Adv Ther. 2009 Feb; 26(2):170-84. Epub 2009 Feb 23.
Review Antidepressants in the treatment of attention-deficit/hyperactivity disorder. [J Clin Psychiatry. 1997]
Review Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
Popper CW. J Clin Psychiatry. 1997; 58 Suppl 14:14-29; discussion 30-1.
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. [J Clin Psychiatry. 2005]
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, et al. J Clin Psychiatry. 2005 Feb; 66(2):253-9.
Review Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. [J Clin Psychiatry. 1998]
Review Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wender PH. J Clin Psychiatry. 1998; 59 Suppl 7:76-9.
Bupropion effects in attention deficit and conduct disorders. [Can J Psychiatry. 1986]
Bupropion effects in attention deficit and conduct disorders.
Simeon JG, Ferguson HB, Van Wyck Fleet J. Can J Psychiatry. 1986 Aug; 31(6):581-5.

See reviews... See all...

Cited by 6 PubMed Central articles

An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. [J ADHD Relat Disord. 2010]
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.
Wilens TE, Prince JB, Waxmonsky J, Doyle R, Spencer T, Martelon M, Evans M. J ADHD Relat Disord. 2010 Apr 1; 1(3):25-35.
Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial. [Neuropsychiatr Dis Treat. 2005]
Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial.
Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED. Neuropsychiatr Dis Treat. 2005 Sep; 1(3):245-51.
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. [Prim Care Companion J Clin Psy...]
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
Fava M, Rush AJ, Thase ME, Clayton A, Stahl SM, Pradko JF, Johnston JA. Prim Care Companion J Clin Psychiatry. 2005; 7(3):106-13.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Bupropion treatment of attention-deficit hyperactivity disorder in adults.
Bupropion treatment of attention-deficit hyperactivity disorder in adults.
Am J Psychiatry. 1990 Aug ;147(8):1018-20.

PubMed
20-HETE in acute kidney injury.
20-HETE in acute kidney injury.
Kidney Int. 2011 Jan ;79(1):10-3.

PubMed
Dietary patterns and risk of breast cancer.
Dietary patterns and risk of breast cancer.
Br J Cancer. 2011 Feb 1 ;104(3):524-31. Epub 2010 Dec 14 .

PubMed
The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/prot...
The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process.
EMBO J. 2011 Feb 2 ;30(3):468-79. Epub 2010 Dec 14 .

PubMed
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.
Hum Vaccin. 2011 Jan 1 ;7(1):27-36. Epub 2011 Jan 1 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Bupropion treatment of attention-deficit hyperactivity disorder in adults.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information